Cargando…

Recurrence risk factors in stage IA grade 1 endometrial cancer

OBJECTIVES: Patients with early-stage endometrial cancers (EC) with disease recurrences have worse survival outcomes. The purpose of this study was to identify clinical and pathologic factors that predict for all recurrences in stage IA grade 1 (IAG1) EC. METHODS: Records from patients diagnosed wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nwachukwu, Chika, Baskovic, Mana, Von Eyben, Rie, Fujimoto, Dylann, Giaretta, Stephanie, English, Diana, Kidd, Elizabeth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology; Japan Society of Gynecologic Oncology 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7930446/ https://www.ncbi.nlm.nih.gov/pubmed/33470064 http://dx.doi.org/10.3802/jgo.2021.32.e22

Ejemplares similares

Racial disparities in outcomes for high‐grade uterine cancer: A California cancer registry study
por: Baskovic, Mana, et al.
Publicado: (2018)

Prognostic factors for tumor recurrence in endometrioid endometrial cancer stages IA and IB
por: Han, Kyung Hee, et al.
Publicado: (2017)

Fertility-Sparing Treatment in Young Patients With Grade 2 Presumed Stage IA Endometrioid Endometrial Adenocarcinoma
por: Yu, Mei, et al.
Publicado: (2020)

Outcomes of Adjuvant Therapy for Stage IA Serous Endometrial Cancer
por: Donovan, Elysia, et al.
Publicado: (2018)

The prognosis of stage IA synchronous endometrial endometrioid and ovarian carcinomas
por: Zhan, Xiangbo, et al.
Publicado: (2019)

Significant difference in recurrence according to the proportion of high grade patterns in stage IA lung adenocarcinoma
por: Jeon, Hyun Woo, et al.
Publicado: (2021)

Fertility-Sparing Approach in Patients with Endometrioid Endometrial Cancer Grade 2 Stage IA (FIGO): A Qualitative Systematic Review
por: Giampaolino, Pierluigi, et al.
Publicado: (2022)

Pilot study of combined FDG‐PET and dynamic contrast‐enhanced CT of locally advanced cervical carcinoma before and during concurrent chemoradiotherapy suggests association between changes in tumor blood volume and treatment response
por: Banks, Thomas I., et al.
Publicado: (2018)

Distant recurrence in a patient with polyp-confined stage IA serous endometrial carcinoma treated with adjuvant chemotherapy: A case report and review of literature
por: Welp, Annalyn, et al.
Publicado: (2019)

The Prognostic Value of Retroperitoneal Lymphadenectomy in Apparent Stage IA Endometrial Endometrioid Cancer
por: Liu, Zhao, et al.
Publicado: (2021)

Effectiveness of Megestrol for the Treatment of Patients with Atypical Endometrial Hyperplasia or Endometrial Endometrioid Adenocarcinoma (Stage IA, Well Differentiated)
por: Akhavan, Setareh, et al.
Publicado: (2021)

Prognosis and adjuvant chemotherapy for patients with positive peritoneal cytology in stage IA endometrial cancer
por: Kanno, Motoko, et al.
Publicado: (2022)

Oncological outcomes in fertility-sparing treatment in stage IA-G2 endometrial cancer
por: Ronsini, Carlo, et al.
Publicado: (2022)

Molecular Evaluation of Low-grade Low-stage Endometrial Cancer With and Without Recurrence
por: Matrai, Cathleen E., et al.
Publicado: (2022)

A Risk Model for Patients with PSA-Only Recurrence (Biochemical Recurrence) Based on PSA and PSMA PET/CT: An Individual Patient Data Meta-Analysis
por: von Eyben, Rie, et al.
Publicado: (2022)

Effects of radiotherapy on the survival of patients with stage IA and low-grade stage IB uterine endometrioid carcinoma
por: Li, Shuqing, et al.
Publicado: (2023)

Pretest PSA and Restaging PSMA PET/CT Predict Survival in Biochemically Recurrent Prostate Cancer
por: von Eyben, Rie, et al.
Publicado: (2023)

Correction: von Eyben et al. A Risk Model for Patients with PSA-Only Recurrence (Biochemical Recurrence) Based on PSA and PSMA PET/CT: An Individual Patient Data Meta-Analysis. Cancers 2022, 14, 5461
por: von Eyben, Rie, et al.
Publicado: (2023)

(68)Ga-PSMA PET/CT for Patients with PSA Relapse after Radical Prostatectomy or External Beam Radiotherapy
por: von Eyben, Finn Edler, et al.
Publicado: (2021)

Different multiparametric MRI-based radiomics models for differentiating stage IA endometrial cancer from benign endometrial lesions: A multicenter study
por: Bi, Qiu, et al.
Publicado: (2022)

Volume Index is a Risk Factor for Recurrence Even in Patients with Clinical Stage IA Endometrial Cancer Undergoing either Laparotomy or Laparoscopy: A Retrospective Study
por: Chikazawa, Kenro, et al.
Publicado: (2022)

CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence
por: Kurnit, Katherine C., et al.
Publicado: (2017)

Predictive factors of recurrence after resection of subsolid clinical stage IA lung adenocarcinoma
por: Im, Dong Jin, et al.
Publicado: (2021)

Disparities in the surgical staging of high-grade endometrial cancer in the United States
por: Foote, Jonathan R., et al.
Publicado: (2017)

Evaluation of Survival, Recurrence Patterns and Adjuvant Therapy in Surgically Staged High-Grade Endometrial Cancer with Retroperitoneal Metastases
por: McEachron, Jennifer, et al.
Publicado: (2021)

Whole-lesion apparent diffusion coefficient (ADC) histogram as a quantitative biomarker to preoperatively differentiate stage IA endometrial carcinoma from benign endometrial lesions
por: Zhang, Jieying, et al.
Publicado: (2022)

Immune Microenvironment Signatures as Biomarkers to Predict Early Recurrence of Stage Ia-b Lung Cancer
por: Wang, Qiang, et al.
Publicado: (2021)

Reirradiation with stereotactic body radiation therapy after prior conventional fractionation radiation for locally recurrent pancreatic adenocarcinoma
por: Koong, Amanda J., et al.
Publicado: (2017)

Prediction of tumor grade and stage in endometrial carcinoma by preoperative assessment of sonographic endometrial thickness: Is it possible?
por: Çakıroğlu, Yiğit, et al.
Publicado: (2014)

The role of endometrial sampling for surveillance of recurrence in postmenopausal patients with medically inoperable stage I endometrial cancer
por: Carey-Love, Angelina, et al.
Publicado: (2020)

Deep learning-enhanced radiomics for histologic classification and grade stratification of stage IA lung adenocarcinoma: a multicenter study
por: Pei, Guotian, et al.
Publicado: (2023)

Five-year disease-free survival in FIGO IA stage endometrial cancer patients: Tertiary institution experience in a developing country
por: Radojević, Marija Živković, et al.
Publicado: (2023)

Effectiveness of weight-loss prevention with continual nutrition counseling in postoperative outpatients with stage IA and IB gastric cancer
por: Matsushita, Asami, et al.
Publicado: (2023)

Race and Gender Shift among Academic Glaucoma Specialists in the Last 5 Decades
por: Afzali, Kasra, et al.
Publicado: (2023)

A recurrent idiotype on monoclonal anti-human Ia antibodies
Publicado: (1982)

Baseline risk of recurrence in stage I–II endometrial carcinoma
por: Sasada, Shinsuke, et al.
Publicado: (2018)

3IA Conference (3IA’2011)
por: Plemenos, Dimitri, et al.
Publicado: (2012)

Hormone Therapy Reduces Recurrence in Stage II-IV Uterine Low-Grade Endometrial Stromal Sarcomas: A Retrospective Cohort Study
por: Huang, Xiaodi, et al.
Publicado: (2022)

Hematologic inflammatory indexes as a prognostic factor in endometrial cancer grading and staging
por: Mohamadianamiri, Mahdiss, et al.
Publicado: (2023)

Treatment selection with organoids in an EGFRm + TP53m stage IA1 patient with recurrence after radical surgery
por: Yamauchi, Yoshikane, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o6kcfucic1lf01h7e9nsh9fqkf